European Journal of Cancer Prevention · Nov 17, 2026
Healthy lifestyle adherence and insulin resistance in prostate cancer patients undergoing radiotherapy: baseline findings from the MicroStyle study
By Doi G, Bellerba F, Repetti I et al.
Radiotherapy in prostate cancer (PCa) may induce side effects and reduced quality of life (QoL). Diet and physical activity may improve prognosis and treatment outcomes, potentially through modulation of insulin resistance. The aim of this cross-sectional subanalysis of the MicroStyle trial is to investigate the association of adherence to a healthy lifestyle with insulin resistance in PCa patients before radiotherapy, and to study the interrelations between lifestyle adherence, insulin resistance, hormonal biomarkers, inflammatory, and psychosocial variables. Insulin resistance was measured via Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Lifestyle adherence was quantified using the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score, and participants were classified as adherent if they had a WCRF/AICR score above the cohort median. Associations between WCRF/AICR adherence, HOMA-IR, biomarkers, and psychosocial factors were evaluated using univariate and multivariable logistic regression, supported by network analysis. Baseline adherence to WCRF/AICR recommendations was independently associated with lower HOMA-IR, with approximately 60% significantly lower odds of insulin resistance (odds ratio = 0.39, 95% confidence interval: 0.22–0.67). Higher HOMA-IR was observed in patients on hormone therapy ( P < 0.001) and those with a stronger tendency to control others ( P = 0.02), adjusting for sex hormone-binding globulin ( P < 0.001) and adiponectin ( P = 0.01), which emerged as significant biomarkers. This study revealed clear associations between lifestyle, metabolic health, and psychological factors. Promoting a healthy lifestyle and psychological support in PCa patients may improve metabolic health.